Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Dana-Farber Cancer Institute
Kivu Bioscience Inc.
National Institutes of Health Clinical Center (CC)
AstraZeneca
BeOne Medicines
ViroMissile, Inc.
Arcus Biosciences, Inc.
Pfizer
Tizona Therapeutics, Inc
National Institutes of Health Clinical Center (CC)
Normunity AccelCo, Inc.
BioNTech SE
Eli Lilly and Company
NiKang Therapeutics, Inc.
Poseida Therapeutics, Inc.
IDEAYA Biosciences
MacroGenics
SystImmune Inc.
Pheon Therapeutics
SN BioScience
Cue Biopharma
Eli Lilly and Company
Doma Biopharmaceutical(Suzhou)Co., Ltd.
Eli Lilly and Company
Seagen Inc.
Seagen Inc.
Innate Pharma
Novartis
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
MOMA Therapeutics
Fate Therapeutics
NextCure, Inc.
Seagen Inc.
University Health Network, Toronto
NeoTX Therapeutics Ltd.
Blueprint Medicines Corporation
Radiopharm Theranostics, Ltd
Bolt Biotherapeutics, Inc.
SystImmune Inc.
Incyte Corporation
National Cancer Institute (NCI)
Actym Therapeutics, Inc.
NiKang Therapeutics, Inc.
EtiraRx Australia Pty Ltd
Pfizer
Elicio Therapeutics